stride semaglutide boosts walking ability in diabetes patients with peripheral artery disease, clinical trial finds Semaglutide in peripheral artery disease

For the first time, the NZSA podcast reaches outside of Anaesthesia with special guest, finance expert and The Curve co-founder, Victoria Harris

GLP-1 weight-loss drugs are cutting calories and grocery bills, according to a new study from Cornells SC Johnson College of Business using data from Numerator

'Lipo-literacy' fuelling weight loss as a moral panic Fuelling a surge in diet culture, according to RMIT University's Dr Natalie Jovanovski, is the collision of "health and aesthetic concerns"

Neuroprotective Effects: There is growing evidence that GLP-1 may protect against neurodegeneration, possibly offering a new avenue for addressing cognitive decline or Alzheimers disease

A private prescription for semaglutide costs roughly 100 a month, and many doctors feel that obese patients should be offered the treatment on the NHS before serious conditions such as type 2 diabetes develop

The program also includes regular medical check-ins with your healthcare provider to monitor your progress and make any necessary adjustments to your treatment plan